Physician profile
Phillip Moore
NPI 1215119151
$3,548.73
in general payments reported to CMS, 2019-2025
24 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,891 · 2020: $40.22 · 2021: $452 · 2022: $313 · 2023: $228 · 2024: $483 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837 · Entertainment: $15.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.33 |
| Entertainment | $15.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $988.92 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $523.60 | 2019 | |
| Silk Road Medical, INC. | $466.51 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Penumbra, INC. | $361.20 | 2019-2025 | Ruby Coil, Penumbra System |
| Cook Medical LLC | $170.95 | 2022-2024 | Cook, Rosen |
| Shockwave Medical, INC | $147.87 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cvrx, INC. | $127.44 | 2022 | |
| Getinge USA Sales, LLC | $123.92 | 2019 | |
| Medtronic Vascular, INC. | $84.27 | 2019 | |
| Boston Scientific Corporation | $81.35 | 2021-2025 | Varithena Administration Pack, Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $79.75 | 2021-2023 | Venaseal, In.Pact Admiral |
| Bard Peripheral Vascular, INC. | $72.60 | 2019 | |
| Inari Medical, INC. | $68.32 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanara Medtech INC. | $42.42 | 2025 | Celleraterx |
| Amgen INC. | $39.51 | 2023-2024 | Repatha |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $37.10 | 2025 | Teg6s Hemostasis System |
| Angiodynamics, INC. | $32.47 | 2020-2024 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $24.72 | 2024 | Perclose Proglide |
| Tactile Systems Technology INC | $17.74 | 2021 | |
| Novo Nordisk INC | $16.32 | 2024 | Wegovy |
| Musculoskeletal Transplant Foundation INC. | $15.50 | 2023 | |
| Janssen Pharmaceuticals, INC | $14.79 | 2021 | |
| Surmodics, INC. | $7.06 | 2022 | |
| Lemaitre Vascular, INC. | $4.40 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.